A complete guide to keratosis pilaris (KP) — the follicular hyperkeratinization condition producing rough bumps on upper arms, thighs, cheeks, and buttocks, its genetic basis (filaggrin gene variants linking it to atopic dermatitis), why KP cannot be cured but can be effectively managed, the evidence-based treatment options (urea 10–20% for keratolysis, lactic acid 12% for exfoliation, salicylic acid 2% for follicular penetration, tretinoin for cell turnover), why physical scrubbing worsens KP, the seasonal pattern, and skin care approaches that flatten the bumps over months of consistent use.
· By MedSpot Editorial · 5 min read
Keratosis pilaris affects an estimated 40% of adults and 80% of adolescents — yet it is chronically undertreated because many patients assume the rough bumps are permanent and untreatable. They are manageable. Here is the complete evidence-based guide.
Keratosis pilaris (KP) is a follicular keratinization disorder — excess keratin accumulates in and around the follicular opening (infundibulum), forming a hard plug that traps the hair inside the follicle and produces the characteristic rough, elevated bump.
The plugs are not blackheads (oxidized sebum) or whiteheads (bacteria-infected sebum). They are keratin plugs — solidified protein from abnormal shedding of keratinocytes at the follicular opening. The associated redness (in the erythematous variant, KPA) is perifollicular inflammation responding to the trapped hair.
Locations: Most commonly upper arms (posterior surface), thighs (anterior and lateral), buttocks, and cheeks (in children; less common in adults). The distribution reflects where the follicular infundibulum has limited natural exfoliation compared to sebum-rich areas.
KP runs in families — it is inherited in an autosomal dominant pattern with incomplete penetrance. The most established genetic link is to filaggrin (FLG) gene variants:
Filaggrin is the structural protein of the stratum corneum — it cross-links keratin filaments and is the primary precursor for natural moisturizing factor (NMF) components. FLG loss-of-function variants cause:
This genetic overlap explains the well-documented association: patients with atopic dermatitis (which is also strongly linked to FLG variants) have higher KP prevalence than the general population.
The implication: KP is not a surface cleansing or hygiene issue — it is a genetically determined keratinocyte behavior that cannot be normalized by washing more thoroughly.
Urea at keratolytic concentrations (10–20%) is the most evidence-supported treatment for KP:
Mechanism: Urea disrupts hydrogen bonds between keratin protein chains — softening and loosening the keratinous plug from within. At 10%, it is both humectant and mildly keratolytic; at 20%, keratolytic activity predominates.
Urea 10–20% creams (CeraVe SA Cream, Eucerin UreaRepair, Carmol 10/20) applied once or twice daily consistently reduce the plug height and surface roughness over 4–8 weeks. These formulations are also appropriate for the face (KP on cheeks) at 10%, though 20% may be too strong for facial skin.
The most widely available OTC keratolytic option for KP. Lactic acid at 12% provides both AHA exfoliation (corneodesmsome cleavage at the skin surface) and humectant function (NMF mimicry):
Evidence: AmLactin 12% lotion is widely recommended by dermatologists specifically for KP and has documented improvement in roughness and bump height with consistent use. The once or twice daily application regimen is the same as prescription agents.
Mechanism: Lactic acid at this concentration at skin pH provides meaningful free-acid activity — corneodesmosome disruption accelerates surface desquamation, thinning the keratinous plug over time.
BHA's lipophilic follicular penetration allows it to reach into the plugged follicle opening where AHAs cannot efficiently access. Salicylic acid loosens the plug from inside the follicle rather than just at the surface.
Best format for KP: Leave-on body lotion or gel formulation (not a wash-off cleanser). CeraVe SA Smoothing Cream and Paula's Choice BHA body lotions are commonly used.
Combination approach: Salicylic acid + lactic acid or urea together (either as a combined product or in alternating application) addresses the plug both from inside the follicle (BHA) and at the surface (AHA/urea).
Tretinoin accelerates epidermal cell turnover, normalizing the follicular keratinization that creates KP plugs. Evidence for tretinoin in KP is extrapolated from its mechanism (the same follicular normalization that addresses acne comedones) and clinical use rather than dedicated KP RCTs.
Best for: Facial KP (cheeks) where other keratolytic agents may be too irritating. More appropriate for motivated patients willing to manage retinoid side effects.
For refractory or severe KP. Prescription-strength urea 40% provides aggressive keratolysis — used in a limited area for a defined period rather than widespread daily use. Appropriate for thick, adherent plugs unresponsive to OTC options.
Physical scrubbing: Loofahs, body brushes, and scrubs applied with force to KP temporarily smooth the surface but trigger post-inflammatory perifollicular inflammation — worsening the redness component and potentially generating new plugs as the disturbed keratinocytes respond to irritation. Gentle exfoliation is fundamentally different from aggressive scrubbing.
Hot water: Hot showers accelerate TEWL and dry the skin — worsening the barrier defect underlying KP. Lukewarm water and limited shower duration help.
Skipping moisturizer: The barrier dysfunction in KP-prone skin requires daily moisturization. Plugs worsen in dry conditions and dry seasons — the skin produces more abnormal keratin as barrier stress increases.
KP consistently worsens in winter (low humidity, central heating → drier air → more TEWL → more plug formation) and improves in summer (humidity, natural exfoliation from sweating). This seasonal pattern is a useful diagnostic clue and guides treatment intensity.
KP cannot be cured — the underlying follicular keratinization tendency is genetic and persists. What is achievable with consistent treatment:
Timeline: Consistent daily application of an effective keratolytic (urea 20% or lactic acid 12%) produces visible improvement in 4–8 weeks, with continued improvement over 3–6 months.
Maintenance: KP returns if treatment is stopped for 4–8 weeks. It requires ongoing management like any chronic skin condition.
Looking for a skincare consultation? Browse med spa providers on MedSpot →